kantrexil (suspension)
bristol-myers squibb (holdings) limited - kanamycin attapulgite pectin bismuth camphocarbonate -
kantrexil suspension
opus -
kantrexil tablets
opus -
pantrex 100mg/ml (500mg/5ml) solution for injection (iv)
pan-ject pharmaceuticals corp.; distributor: pan-ject pharmaceuticals corp. - tranexamic acid - solution for injection (iv) - 100mg/ml (500mg/5ml)
acetylcysteine solution
sandoz canada incorporated - acetylcysteine - solution - 200mg - acetylcysteine 200mg - antidotes
acetylcysteine solution usp
hikma canada limited - acetylcysteine - solution - 200mg - acetylcysteine 200mg - antidotes
acetylcysteine solution usp
sterimax inc - acetylcysteine - solution - 200mg - acetylcysteine 200mg
difolta
rafa laboratories ltd - pralatrexate - solution for injection - pralatrexate 20 mg/ml - pralatrexate - pralatrexate - for the treatment of patients with relapsed or refractory peripheral t-cell lymphoma (ptcl).
folotyn pralatrexate 20 mg in 1 ml injection, intravenous infusion vial
mundipharma pty ltd - pralatrexate, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: sodium chloride; hydrochloric acid; water for injections; sodium hydroxide - folotyn is indicated for the treatment of adult patients with peripheral t-cell lymphoma (nodal, extranodal, and leukaemic/disseminated) who have progressed after at least one prior therapy.
folotyn pralatrexate 40 mg in 2 ml injection, intravenous infusion vial
mundipharma pty ltd - pralatrexate, quantity: 20 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; sodium hydroxide; sodium chloride; water for injections - folotyn is indicated for the treatment of adult patients with peripheral t-cell lymphoma (nodal, extranodal, and leukaemic/disseminated) who have progressed after at least one prior therapy.